Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin

Introduction: Kidney fibrosis has shown to be ameliorated through the involvement of cyclic guanosine monophosphate (cGMP) and its dependent protein kinase I (cGKI). Serelaxin, the recombinant form of human relaxin-II, increases cGMP levels and has shown beneficial effects on kidney function in acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetzl, Veronika, Schinner, Elisabeth, Kees, Frieder, Hofmann, Franz, Faerber, Lothar, Schlossmann, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940422/
https://www.ncbi.nlm.nih.gov/pubmed/27462268
http://dx.doi.org/10.3389/fphar.2016.00195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940422/
https://www.ncbi.nlm.nih.gov/pubmed/27462268
http://dx.doi.org/10.3389/fphar.2016.00195

Ejemplares similares